PARP & DDR Inhibitors Summit 2020

In January 2020 the Chiefs, Heads and Directors of the DNA Damage Response field will gather at the PARP & DNA Damage Response (DDR) Inhibitors Summit to push PARP into wider indications and accelerate novel target development. Hear from experts at Merck KGaA, Bayer, AstraZeneca and many more, as they race to find best-in-class PARPi and discuss novel and emerging targets in the exploding DDR field.
Equip yourselves with the knowledge and expertise to optimize your DNA Damage Response therapeutics, find the best combination strategies and overcome drug resistance. Learn from trailblazers such as Frank Zenke, Geoffrey Shapiro and Mitch Raponi, who will assemble to address key challenges and devise strategies to maximize the therapeutic potential of DDR targets.
This is the industry-focused end-to-end meeting to attend this year. A unique opportunity to meet with the VPs, Heads and Directors of Translational Oncology, Target Discovery and Early Drug Development to accelerate your DDR pipeline